| Trial ID: | L0891 |
| Source ID: | NCT01222234
|
| Associated Drug: |
Cholecalciferol - Ckd
|
| Title: |
Impact of Vitamin D Therapies on Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01222234/results
|
| Conditions: |
Chronic Kidney Disease (CKD)|End-stage Renal Disease (ESRD)
|
| Interventions: |
DRUG: Cholecalciferol - CKD|DEVICE: Calcitriol - CKD|DRUG: Cholecalciferol - non-CKD
|
| Outcome Measures: |
Primary: Monocyte Protein Expression, Flow cytometry analysis of monocyte CD14, ACE, VDR, and Mac-1 expression, 8 weeks of therapy|Change in 24,25(OH)2D Levels in CKD vs. Non-CKD Subjects Receiving Cholecalciferol, 8 weeks of therapy |
|
| Sponsor/Collaborators: |
Sponsor: University of Kansas Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
56
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2010-10
|
| Completion Date: |
2012-08
|
| Results First Posted: |
2016-05-16
|
| Last Update Posted: |
2016-05-16
|
| Locations: |
University Of Kansas Medical Center, Kansas City, Kansas, 66160, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01222234
|
